Learn More
Medchemexpress LLC Raloxifene hydrochloride | 82640-04-8 | 99.8% | 510.04 | 25 MG

Supplier: Medchemexpress LLC 25MGHY13738AR
Raloxifene hydrochloride is a second-generation, selective, and orally active estrogen receptor modulator. It exhibits estrogen-agonistic effects on bone and lipid metabolism, while demonstrating estrogen-antagonistic effects on uterine endometrium and breast tissue.
- Activates TGF beta 3 promoter as a full agonist
- Inhibits estrogen response element-containing vitellogenin promoter expression
- Acts as a potent uncompetitive inhibitor of human liver aldehyde oxidase
- Functions as a noncompetitive inhibitor of aldehyde oxidase-catalyzed reduction reactions
- Decreases viability in mouse mammary carcinoma cells
- Demonstrates estrogenic activity on bone resorption and serum cholesterol in ovariectomized rats
- Increases bone mineral density in ovariectomized rats
- Reduces serum cholesterol in ovariectomized rats
- Suppresses tumor volumes and decreases lymph node metastasis in mice
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.